 |
Conference papers
CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY
Mathilde Tardieu 1 Sophie Duvert Lehembre Islam Amine Larabi 2 Johannes Visser 3 Caroline Hutter 4 Valérie Taly 5 Matthew J. Collins 6 Alvarez Jc. Emile J.F. Sébastien Héritier 7 Jean Donadieu 8
Mathilde Tardieu 1
Author
Sophie Duvert Lehembre
Author
Islam Amine Larabi 2
Author
Johannes Visser 3
Author
Caroline Hutter 4
Author
Valérie Taly 5
Author
IdHAL : valerie-talyIdRef : 161486983
Matthew J. Collins 6
Author
Alvarez Jc.
Author
1
CHU - Centre Hospitalier Universitaire [Grenoble] (CS 10217
38043 Grenoble cedex 9 - France)
2
Hôpital Raymond Poincaré [AP-HP] (104 Boulevard Raymond Poincaré, 92380 Garches - France)
3
CUH - Cambridge University Hospitals - NHS (Foundation Trust Cambridge Biomedical Campus Hills Road Cambridge CB2 0QQ - United Kingdom)
- CAM - University of Cambridge [UK] (The Old Schools, Trinity Lane, Cambridge CB2 1TN - United Kingdom)
4
Medizinische Universität Wien = Medical University of Vienna (Spitalgasse 23, A-1090 Vienna - Austria)
5
MEPPOT - U1147 - Médecine Personnalisée, Pharmacogénomique, Optimisation Thérapeutique (Centre Universitaire des Saints Pères - 45 rue des Saints Pères 75006 Paris - France)
- UPD5 - Université Paris Descartes - Paris 5 : UMR_S 1147 (12, rue de l'École de Médecine - 75270 Paris cedex 06 - France)
- INSERM - Institut National de la Santé et de la Recherche Médicale : U1147 (101, rue de Tolbiac, 75013 Paris - France)
6
CUDOS - Centre for Ultrahigh Bandwidth Devices for Optical Systems (Institute of Photonics and Optical Science (IPOS), School of Physics, University of Sydney, NSW 2006, Australia - Australia)
- The University of Sydney (New South Wales 2006 - Australia)
7
CHU Trousseau [APHP] (26 Avenue du Dr Arnold Netter, 75012 Paris - France)
- AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) (France)
- SU - Sorbonne Université (21 rue de l’École de médecine - 75006 Paris - France)
8
Service d'hématologie-immunologie-oncologie pédiatrique [CHU Trousseau] (26, avenue du Docteur Arnold-Netter 75571 PARIS Cedex 12 - France)
- CHU Trousseau [APHP] (26 Avenue du Dr Arnold Netter, 75012 Paris - France)
- AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) (France)
- SU - Sorbonne Université (21 rue de l’École de médecine - 75006 Paris - France)
Document type :
Conference papers
Domain :
Complete list of metadata
https://www.hal.inserm.fr/inserm-02413491
Contributor : Valerie TALY Connect in order to contact the contributor
Submitted on : Monday, December 16, 2019 - 11:21:27 AM
Last modification on : Sunday, June 26, 2022 - 1:07:47 AM
Contributor : Valerie TALY Connect in order to contact the contributor
Submitted on : Monday, December 16, 2019 - 11:21:27 AM
Last modification on : Sunday, June 26, 2022 - 1:07:47 AM
Identifiers
- HAL Id : inserm-02413491, version 1
Collections
Citation
Mathilde Tardieu, Sophie Duvert Lehembre, Islam Amine Larabi, Johannes Visser, Caroline Hutter, et al.. CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY. 34th Annual Meeting of the Histiocyte Society Lisbon, Portugal, October 22–23, 2018, Oct 2019, Lisbon, Portugal. pp.S46-S47. ⟨inserm-02413491⟩
Metrics
Record views